---
figid: PMC2934757__nihms216911f1a
figtitle: Defining the pathway to insulin-like growth factor system targeting in cancer
organisms:
- Homo sapiens
- Mus musculus
- Escherichia coli
- Betapolyomavirus macacae
- Silybum marianum
pmcid: PMC2934757
filename: nihms216911f1a.jpg
figlink: /pmc/articles/PMC149053/figure/fig7/
number: F1a
caption: (a) IGF System Components. Shown are the ligands, IGF-1/IGF-2, the receptors,
  IGF-1R, IR-A, IR-B and hybrid IGF-1R:IR-A and IGF-1R:IR-B receptors and IGFBPs.
  The mAbs and TKIs targeting the IGF-1R is an incomplete list.(1b) Targeting the
  Tumor Microenvironment IGF System. Within the tumor microenvironment, multiple cell
  types secrete IGF-1 that diffuses to tumor cells to enhance tumorigenesis. IGFBP
  inhibition of IGF-1 and IGF-2 is well suited for the tumor microenvironment where
  multiple sources of IGF-1 exist. Also shown is increased angiogenesis mediated by
  VEGF downstream of IGF-1R action [, , ].
papertitle: Defining the pathway to insulin-like growth factor system targeting in
  cancer.
reftext: Steven A. Rosenzweig, et al. Biochem Pharmacol. ;80(8):1115-1124.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9627062
figid_alias: PMC2934757__F1a
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC2934757__F1a
ndex: a9c0424b-dece-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2934757__nihms216911f1a.html
  '@type': Dataset
  description: (a) IGF System Components. Shown are the ligands, IGF-1/IGF-2, the
    receptors, IGF-1R, IR-A, IR-B and hybrid IGF-1R:IR-A and IGF-1R:IR-B receptors
    and IGFBPs. The mAbs and TKIs targeting the IGF-1R is an incomplete list.(1b)
    Targeting the Tumor Microenvironment IGF System. Within the tumor microenvironment,
    multiple cell types secrete IGF-1 that diffuses to tumor cells to enhance tumorigenesis.
    IGFBP inhibition of IGF-1 and IGF-2 is well suited for the tumor microenvironment
    where multiple sources of IGF-1 exist. Also shown is increased angiogenesis mediated
    by VEGF downstream of IGF-1R action [, , ].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGFBP1
  - IGFBP2
  - IGFBP3
  - IGFBP4
  - IGFBP5
  - IGFBP6
  - IGFBP7
  - IGF1
  - IGF2
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - IGF1R
  - MTG1
  - IGF2R
  - PTBP1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - GRB2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - MAP2K1
  - MAP2K2
  - IRS2
  - IRS1
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - Igfbp1
  - Igfbp2
  - Igfbp3
  - Igfbp5
  - Igfbp4
  - Igfbp6
  - Igf1
  - Igf2
  - Igf1r
  - Insr
  - Igf2r
  - Ptbp1
  - Shc1
  - ras
  - Hras
  - Kras
  - Rem1
  - Grb2
  - Zhx2
  - Pik3r1
  - Ecm1
  - Ppp1r13b
  - Pik3ca
  - Map2k1
  - Map2k2
  - Irs2
  - Irs1
  - Akt1
  - Mapk3
  - Mapk1
  - BMS-754807
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
